G. Han, “Bimekizumab Efficacy through Year 1 in Patients with Moderate to Severe Plaque Psoriasis Who Had Not Achieved a PASI 90 Response by Week 16: A Pooled Analysis from Four Phase 3/3B Trials”, J of Skin, vol. 8, no. 2, p. s369, Mar. 2024.